Intervacc AB
Intervacc AB (publ) develops novel veterinary vaccines for animals in Sweden. The company's product pipeline includes Stangvac, a vaccine against equine strangles for horses; INV274, antigens for a vaccine against streptococcus suis for the treatment of weaned piglets; and INV412, a multi-component vaccine to protect against several bacteria which cause mastitis for treating cows. It also engages… Read more
Intervacc AB (IVACC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.094x
Based on the latest financial reports, Intervacc AB (IVACC) has a cash flow conversion efficiency ratio of -0.094x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-29.33 Million) by net assets (Skr310.46 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Intervacc AB - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Intervacc AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Intervacc AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Intervacc AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Surgepays Inc
NASDAQ:SURG
|
0.723x |
|
Smart Digital Group Limited Ordinary Shares
NASDAQ:SDM
|
N/A |
|
Malmbergs Elektriska AB (publ)
ST:MEAB-B
|
-0.016x |
|
Kapston Services Limited
NSE:KAPSTON
|
0.016x |
|
Koryo Electronics Co Ltd
TWO:8032
|
-0.030x |
|
Mestron Holdings
KLSE:0207
|
0.194x |
|
Orient Bell Limited
NSE:ORIENTBELL
|
0.037x |
|
LANSON-BCC INH. EO 10
F:GQ6
|
N/A |
Annual Cash Flow Conversion Efficiency for Intervacc AB (2015–2024)
The table below shows the annual cash flow conversion efficiency of Intervacc AB from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr162.33 Million | Skr-53.20 Million | -0.328x | -70.11% |
| 2023-12-31 | Skr237.93 Million | Skr-45.83 Million | -0.193x | +30.95% |
| 2022-12-31 | Skr250.16 Million | Skr-69.79 Million | -0.279x | -237.73% |
| 2021-12-31 | Skr308.25 Million | Skr-25.46 Million | -0.083x | -38.88% |
| 2020-12-31 | Skr337.61 Million | Skr-20.08 Million | -0.059x | -372.02% |
| 2019-12-31 | Skr219.82 Million | Skr-2.77 Million | -0.013x | +40.50% |
| 2018-12-31 | Skr190.43 Million | Skr-4.03 Million | -0.021x | +81.77% |
| 2017-12-31 | Skr164.90 Million | Skr-19.16 Million | -0.116x | -260.12% |
| 2016-12-31 | Skr130.18 Million | Skr-4.20 Million | -0.032x | +78.61% |
| 2015-12-31 | Skr126.52 Million | Skr-19.09 Million | -0.151x | -- |